Navigation Links
PSivida in Medical News

Alimera Sciences Closes $30 Million in Series C Financing, Increasing Stake in Medidur(TM) FA

...acquire a majority stake in Medidur(TM) FA, the company's Phase III investigative treatment for diabetic macular edema (DME), from development partner psivida Ltd (Nasdaq: PSDV , ASX: PSD, Xetra: PSI) and fund the remaining development obligations for the product. Under the new agreement, Alimera will ass...

DSMB Supports Continuation of the Phase 3 Clinical Trial of Medidur(TM) FA for the Treatment of DME

...the recruitment phase of this pivotal study," said psivida Limited Managing Director, Dr. Paul Ashton. Curre...ease visit http://www.alimerasciences.com About psivida Limited pSivida, a Boston, MA. based global drug ...) technology which underpins the Medidur product. psivida owns the rights to develop and commercialize a mod...

PSivida, Pfizer Ink $165 Million Licensing Pact

... Perth-based bio-nanotech major, psivida Limited has signed an exclusive worldwide Collabor...lications. Under the terms of the agreement, psivida will receive up to $155 million in development and...laboration in ophthalmic applications and will pay psivida a royalty on net sales of those products. I...
PSivida in Medical Technology

Enrollment Complete in Pivotal Phase 3 Trial of Medidur(TM) FA for Diabetic Macular Edema

...vately held ophthalmic pharmaceutical company, and psivida Limited (Nasdaq: PSDV; ASX: PSD; Xetra: PSI), anno...ficacy assessed at two years. Alimera Sciences and psivida are jointly developing Medidur FA under a collabor...ease visit http://www.alimerasciences.com About psivida Limited ...

Enrollment Begins on Human PK Study for Medidur(TM) FA

...vately held ophthalmic pharmaceutical company, and psivida Limited (Nasdaq: PSDV , ASX: PSD, Xetra: PSI) tod...ls in the anterior chamber." Alimera Sciences and psivida Limited have a worldwide agreement to co-develop a...r," said Dr Paul Ashton, PhD, Managing Director of psivida Limited. "Additionally, by determining anterior ch...
PSivida in Biological Technology

Alimera Sciences, pSivida Limited Amend Medidur(TM) FA Collaboration Agreement

ATLANTA and BOSTON, March 17 /PRNewswire-FirstCall/ -- Alimera Sciences and pSivida Ltd (Nasdaq: PSDV ; ASX: PSD; Xetra: PSI) today announced that they have amended their license and collaboration agreement relating to Medidur(TM) FA, the companies' Phase III investigative treatment for diabe...
Other Tags
(Date:7/27/2014)... 2014 The constant expansion of companies ... demand for enterprise video. Additional factors that have increased ... areas such as corporate communication, learning and development, security ... all these factors the enterprise video market value has ... reach $35.57 billion in 2018 with a compound annual ...
(Date:7/27/2014)... 27, 2014 The North American security ... at $1570 million in 2014, and it is expected ... of 4.64%. The report incorporates the factors that influence ... of growth rates and projected total expenditure. The report ... global markets. Apart from the general overview of the ...
(Date:7/27/2014)... York City (Sunday July 27 11:45 am ... operationsinfection at the surgical sitehas been reduced by ... participation in the American College of Surgeons National ... a new case study presented at the 2014 ... Vancouver, British Columbia, reportedly reduced its rate of ...
(Date:7/27/2014)... The report provides market analysis ... Market Analysis (Commercial Aviation And Defense Aviation Landing ... - Forecasts 2014 - 2019." The report covers ... shape the market during the study period. It ... that are currently prevailing in the global market. ...
(Date:7/27/2014)... 2014 As Tylenol lawsuits ... move forward in federal court, Bernstein Liebhard LLP ... of the benefits purportedly associated with acetaminophen, the ... which appears in the The Lancet, looked at ... whom were given either acetaminophen or a placebo ...
Breaking Medicine News(10 mins):Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 4Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 2Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 3Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 4Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 5Health News:Surgical safety program greatly reduces surgical site infections for heart operations 2Health News:Surgical safety program greatly reduces surgical site infections for heart operations 3Health News:Surgical safety program greatly reduces surgical site infections for heart operations 4Health News:Actuator Systems Market in Aviation Estimated to Reach $3,839.74 Million by 2019 - New Report by MarketsandMarkets 2Health News:Actuator Systems Market in Aviation Estimated to Reach $3,839.74 Million by 2019 - New Report by MarketsandMarkets 3Health News:Actuator Systems Market in Aviation Estimated to Reach $3,839.74 Million by 2019 - New Report by MarketsandMarkets 4Health News:As Tylenol Lawsuits Mount, Bernstein Liebhard LLP Notes Study Questioning Some Benefits Purportedly Associated with Acetaminophen 2Health News:As Tylenol Lawsuits Mount, Bernstein Liebhard LLP Notes Study Questioning Some Benefits Purportedly Associated with Acetaminophen 3Health News:As Tylenol Lawsuits Mount, Bernstein Liebhard LLP Notes Study Questioning Some Benefits Purportedly Associated with Acetaminophen 4
(Date:7/24/2014)... YORK, NY (July 24, 2014) Scientists at ... Institute are one step closer to creating a ... a patient,s own cells. , For the ... (iPS) cells lines from skin samples of patients ... developed an accelerated protocol to induce these stem ...
(Date:7/24/2014)... -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the ... Phase 3 study of Zerenex (ferric citrate), the Company,s ... of hyperphosphatemia in patients with end-stage renal disease (ESRD) ... delivery with FErric CiTrate in EsrD) was published online ... of Nephrology ( JASN ). , ...
(Date:7/24/2014)... 24, 2014) Scientists at The New York ... step closer to creating a viable cell replacement ... cells. , For the first time, NYSCF ... from skin samples of patients with primary progressive ... protocol to induce these stem cells into becoming ...
Breaking Biology News(10 mins):NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2
Other Contents